1,132
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Homogeneous Polyporus polysaccharide exerts anti-bladder cancer effects via autophagy induction

, , , , &
Pages 214-221 | Received 03 Mar 2023, Accepted 03 Feb 2024, Published online: 14 Feb 2024

References

  • Anderson NM, Simon MC. 2020. The tumor microenvironment. Curr Biol. 30(16):R921–R925. doi: 10.1016/j.cub.2020.06.081.
  • Buffen K, Oosting M, Quintin J, Ng A, Kleinnijenhuis J, Kumar V, van de Vosse E, Wijmenga C, van Crevel R, Oosterwijk E, et al. 2014. Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer. PLoS Pathog. 10(10):e1004485. doi: 10.1371/journal.ppat.1004485.
  • Cao R, Ma B, Wang G, Xiong Y, Tian Y, Yuan L. 2021. Identification of autophagy-related genes signature predicts chemotherapeutic and immunotherapeutic efficiency in bladder cancer (BLCA). J Cell Mol Med. 25(12):5417–5433. doi: 10.1111/jcmm.16552.
  • Casey SC, Amedei A, Aquilano K, Azmi AS, Benencia F, Bhakta D, Bilsland AE, Boosani CS, Chen S, Ciriolo MR, et al. 2015. Cancer prevention and therapy through the modulation of the tumor microenvironment. Semin Cancer Biol. 35 Suppl(Suppl):S199–S223. doi: 10.1016/j.semcancer.2015.02.007.
  • Crispen PL, Kusmartsev S. 2020. Mechanisms of immune evasion in bladder cancer. Cancer Immunol Immunother. 69(1):3–14. doi: 10.1007/s00262-019-02443-4.
  • Denton D, Kumar S. 2019. Autophagy-dependent cell death. Cell Death Differ. 26(4):605–616. doi: 10.1038/s41418-018-0252-y.
  • Gao W, Wang X, Zhou Y, Wang X, Yu Y. 2022. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 7(1):196.
  • Ge Y, Huang M, Yao YM. 2018. Autophagy and proinflammatory cytokines: interactions and clinical implications. Cytokine Growth Factor Rev. 43:38–46. doi: 10.1016/j.cytogfr.2018.07.001.
  • Guo N, Bai Z, Jia W, Sun J, Wang W, Chen S, Wang H. 2019. Quantitative analysis of polysaccharide composition in Polyporus umbellatus by HPLC-ESI-TOF-MS. Molecules. 24(14):2526. doi: 10.3390/molecules24142526.
  • He PF, Zhang AQ, Wang XL, Qu L, Li GL, Li YP, Sun PL. 2016. Structure elucidation and antioxidant activity of a novel polysaccharide from Polyporus umbellatus sclerotia. Int J Biol Macromol. 82:411–417. doi: 10.1016/j.ijbiomac.2015.10.032.
  • Heras-Sandoval D, Pérez-Rojas JM, Hernández-Damián J, Pedraza-Chaverri J. 2014. The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal. 26(12):2694–2701. doi: 10.1016/j.cellsig.2014.08.019.
  • Hu F, Song D, Yan Y, Huang C, Shen C, Lan J, Chen Y, Liu A, Wu Q, Sun L, et al. 2021. IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation. Nat Commun. 12(1):3651. doi: 10.1038/s41467-021-23923-1.
  • Huang Z, Gan S, Zhuang X, Chen Y, Lu L, Wang Y, Qi X, Feng Q, Huang Q, Du B, et al. 2022. Artesunate inhibits the cell growth in colorectal cancer by promoting ROS-dependent cell senescence and autophagy. Cells. 11(16):2472. doi: 10.3390/cells11162472.
  • Jia W, Luo S, Lai G, Li S, Huo S, Li M, Zeng X. 2021. Homogeneous Polyporus polysaccharide inhibits bladder cancer by polarizing macrophages to M1 subtype in tumor microenvironment. BMC Complement Med Ther. 21(1):150. doi: 10.1186/s12906-021-03318-x.
  • Jiang GM, Tan Y, Wang H, Peng L, Chen HT, Meng XJ, Li LL, Liu Y, Li WF, Shan H. 2019. The relationship between autophagy and the immune system and its applications for tumor immunotherapy. Mol Cancer. 18(1):17. doi: 10.1186/s12943-019-0944-z.
  • Konac E, Kurman Y, Baltaci S. 2021. Contrast effects of autophagy in the treatment of bladder cancer. Exp Biol Med (Maywood). 246(3):354–367. doi: 10.1177/1535370220959336.
  • Leblond MM, Zdimerova H, Desponds E, Verdeil G. 2021. Tumor-associated macrophages in bladder cancer: biological role, impact on therapeutic response and perspectives for immunotherapy. Cancers (Basel). 13(18):4712. doi: 10.3390/cancers13184712.
  • Lenis AT, Lec PM, Chamie K, Mshs MD. 2020. Bladder cancer: a review. JAMA. 324(19):1980–1991. doi: 10.1001/jama.2020.17598.
  • Levy JMM, Towers CG, Thorburn A. 2017. Targeting autophagy in cancer. Nat Rev Cancer. 17(9):528–542. doi: 10.1038/nrc.2017.53.
  • Li F, Guo H, Yang Y, Feng M, Liu B, Ren X, Zhou H. 2019. Autophagy modulation in bladder cancer development and treatment (Review). Oncol Rep. 42(5):1647–1655. doi: 10.3892/or.2019.7286.
  • Li X, He S, Ma B. 2020. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 19(1):12. doi: 10.1186/s12943-020-1138-4.
  • Liu CP, Zhang X, Tan QL, Xu WX, Zhou CY, Luo M, Li X, Huang RY, Zeng X. 2017. NF-κB pathways are involved in M1 polarization of RAW 264.7 macrophage by Polyporus polysaccharide in the tumor microenvironment. PLoS One. 12(11):e0188317. doi: 10.1371/journal.pone.0188317.
  • Liu CP, Li X, Lai GN, Li JH, Jia WY, Cao YY, Xu WX, Tan QL, Zhou CY, Luo M, et al. 2020. Mechanisms of macrophage immunomodulatory activity induced by a new polysaccharide isolated from Polyporus umbellatus (Pers.) Fries. Front Chem. 8:581. doi: 10.3389/fchem.2020.00581.
  • Liu C, He D, Zhang S, Chen H, Zhao J, Li X, Zeng X. 2022. Homogeneous Polyporus polysaccharide inhibit bladder cancer by resetting tumor-associated macrophages toward M1 through NF-κB/NLRP3 signaling. Front Immunol. 13:839460. doi: 10.3389/fimmu.2022.839460.
  • Lv S, Liu H, Wang H. 2021. Exogenous hydrogen sulfide plays an important role by regulating autophagy in diabetic-related diseases. Int J Mol Sci. 22(13):6715. doi: 10.3390/ijms22136715.
  • Marinković M, Šprung M, Buljubašić M, Novak I. 2018. Autophagy modulation in cancer: current knowledge on action and therapy. Oxid Med Cell Longev. 2018:8023821–8023818. doi: 10.1155/2018/8023821.
  • Mizushima N, Komatsu M. 2011. Autophagy: renovation of cells and tissues. Cell. 147(4):728–741. doi: 10.1016/j.cell.2011.10.026.
  • Nielsen SR, Schmid MC. 2017. Macrophages as key drivers of cancer progression and metastasis. Mediators Inflamm. 2017:9624760–9624711. doi: 10.1155/2017/9624760.
  • Parzych KR, Klionsky DJ. 2014. An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal. 20(3):460–473. doi: 10.1089/ars.2013.5371.
  • Polivka J, Jr, Janku F. 2014. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol Ther. 142(2):164–175. doi: 10.1016/j.pharmthera.2013.12.004.
  • Roma-Rodrigues C, Mendes R, Baptista PV, Fernandes AR. 2019. Targeting tumor microenvironment for cancer therapy. Int J Mol Sci. 20(4):840. doi: 10.3390/ijms20040840.
  • Shen J, Xu S, Zhou H, Liu H, Jiang W, Hao J, Hu Z. 2017. IL-1β induces apoptosis and autophagy via mitochondria pathway in human degenerative nucleus pulposus cells. Sci Rep. 7(1):41067. doi: 10.1038/srep41067.
  • Sun H, Wang Z, Yakisich JS. 2013. Natural products targeting autophagy via the PI3K/Akt/mTOR pathway as anticancer agents. Anticancer Agents Med Chem. 13(7):1048–1056. doi: 10.2174/18715206113139990130.
  • Towers CG, Wodetzki D, Thorburn A. 2020. Autophagy and cancer: modulation of cell death pathways and cancer cell adaptations. J Cell Biol. 219(1):e201909033. doi: 10.1083/jcb.201909033.
  • Tsai TF, Chang AC, Chen PC, Ho CY, Chen HE, Chou KY, Hwang TI. 2022. Autophagy blockade potentiates cancer-associated immunosuppression through programmed death ligand-1 upregulation in bladder cancer. J Cell Physiol. 237(9):3587–3597. doi: 10.1002/jcp.30817.
  • Udristioiu A, Nica-Badea D. 2019. Autophagy dysfunctions associated with cancer cells and their therapeutic implications. Biomed Pharmacother. 115:108892. doi: 10.1016/j.biopha.2019.108892.
  • van Wilpe S, Gerretsen ECF, van der Heijden AG, de Vries IJM, Gerritsen WR, Mehra N. 2020. Prognostic and predictive value of tumor-infiltrating immune cells in urothelial cancer of the bladder. Cancers (Basel). 12(9):2692. doi: 10.3390/cancers12092692.
  • Vitto VAM, Bianchin S, Zolondick AA, Pellielo G, Rimessi A, Chianese D, Yang H, Carbone M, Pinton P, Giorgi C, et al. 2022. Molecular mechanisms of autophagy in cancer development, progression, and therapy. Biomedicines. 10(7):1596. doi: 10.3390/biomedicines10071596.
  • Xiang Y, Guo Z, Zhu P, Chen J, Huang Y. 2019. Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science. Cancer Med. 8(5):1958–1975. doi: 10.1002/cam4.2108.
  • Xiao Y, Yu D. 2021. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 221:107753. doi: 10.1016/j.pharmthera.2020.107753.
  • Xue JF, Shi ZM, Zou J, Li XL. 2017. Inhibition of PI3K/AKT/mTOR signaling pathway promotes autophagy of articular chondrocytes and attenuates inflammatory response in rats with osteoarthritis. Biomed Pharmacother. 89:1252–1261. doi: 10.1016/j.biopha.2017.01.130.
  • Yuan Y, Ding D, Zhang N, Xia Z, Wang J, Yang H, Guo F, Li B. 2018. TNF-α induces autophagy through ERK1/2 pathway to regulate apoptosis in neonatal necrotizing enterocolitis model cells IEC-6. Cell Cycle. 17(11):1390–1402. doi: 10.1080/15384101.2018.1482150.
  • Zhang G, Zeng X, Li C, Li J, Huang Y, Han L, Wei JA, Huang H. 2011. Inhibition of urinary bladder carcinogenesis by aqueous extract of sclerotia of Polyporus umbellatus Fries and Polyporus polysaccharide. Am J Chin Med. 39(1):135–144. doi: 10.1142/S0192415X11008701.
  • Zhang GW, Qin GF, Han B, Li CX, Yang HG, Nie PH, Zeng X. 2015. Efficacy of Zhuling Polyporus polysaccharide with BCG to inhibit bladder carcinoma. Carbohydr Polym. 118:30–35. doi: 10.1016/j.carbpol.2014.11.012.
  • Zhang Y, He N, Zhou X, Wang F, Cai H, Huang SH, Chen X, Hu Z, Jin X. 2021. Betulinic acid induces autophagy-dependent apoptosis via Bmi-1/ROS/AMPK-mTOR-ULK1 axis in human bladder cancer cells. Aging (Albany NY). 13(17):21251–21267. doi: 10.18632/aging.203441.
  • Zhen Y, Zhao R, Wang M, Jiang X, Gao F, Fu L, Zhang L, Zhou XL. 2020. Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer. Theranostics. 10(18):8080–8097. doi: 10.7150/thno.43473.